carbamates has been researched along with Granulocytic Leukemia, Chronic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bright, SA | 1 |
| Greene, LM | 1 |
| Greene, TF | 1 |
| Campiani, G | 1 |
| Butini, S | 1 |
| Brindisi, M | 1 |
| Lawler, M | 1 |
| Meegan, MJ | 1 |
| Williams, DC | 1 |
| Zisterer, DM | 1 |
1 other study available for carbamates and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
Topics: Antineoplastic Agents; Apoptosis; Benzamides; Blotting, Western; Carbamates; Cell Line, Tumor; Down- | 2009 |